A detailed history of Viking Global Investors LP transactions in Rallybio Corp stock. As of the latest transaction made, Viking Global Investors LP holds 4,194,777 shares of RLYB stock, worth $3.61 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,194,777
Previous 4,194,777 -0.0%
Holding current value
$3.61 Million
Previous $5.62 Million 12.7%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$10.83 - $23.4 $45.4 Million - $98.2 Million
4,194,777 New
4,194,777 $73.7 Million

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $27.6M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.